Therapeutic concentrations of the antidepressants such as amitriptyline and fluoxetine reduce acid sphingomyelinase activity and increase sphingomyelin concentrations in the hippocampus and thereby increase neuronal proliferation, maturation, and survival and normalize behavior in models of stress-induced depression [21–23]. The gene discussed is SMPD1; the disease is major depressive disorder.